本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aptevo Therapeutics Inc.

2.68
-0.0800-2.90%
盤後2.690.0053+0.20%19:45 EDT
成交量:5.53萬
成交額:14.86萬
市值:482.94萬
市盈率:-0.09
高:2.85
開:2.84
低:2.58
收:2.76
52周最高:48.78
52周最低:2.58
股本:180.20萬
流通股本:164.35萬
量比:0.81
換手率:3.36%
股息:- -
股息率:- -
每股收益(TTM):-29.4999
每股收益(LYR):-82.2951
淨資產收益率:-420.34%
總資產收益率:-111.49%
市淨率:0.80
市盈率(LYR):-0.03

資料載入中...

公司資料

公司名字:
Aptevo Therapeutics Inc.
交易所:
NASDAQ
成立時間:
2016
員工人數:
33
公司地址:
2401 4th Avenue,Suite 1050,Seattle,Washington,United States
郵編:
98121
電話:
傳真:
206 838 0503
簡介:
Aptevo Therapeutics Inc.於2016年2月在特拉華州註冊成立。該公司是一家臨床階段的研發生物技術公司,專註於開發用於治療不同形式癌症的新型免疫療法候選者。該公司開發了兩種多功能平台技術,用於合理設計精準免疫調節藥物。

董事

名稱
職位
Jeffrey G. Lamothe
Chief Executive Officer,Director and President
Barbara Lopez Kunz
Independent Director
Daniel J. Abdun Nabi
Independent Director
Grady Grant, III
Independent Director
John E. Niederhuber
Lead Independent Director
Marvin L. White
Director and Executive Chair
Zsolt Harsanyi
Independent Director

股東

名稱
職位
Jeffrey G. Lamothe
Chief Executive Officer,Director and President
Daphne Taylor
Chief Financial Officer and Senior Vice President
Dirk Huebner
Chief Medical Officer and Senior Vice President
Mary Janatpour
Chief Scientific Officer and Senior Vice President
SoYoung Kwon
General Counsel, Business Development and Corporate Affairs and Senior Vice President
Marvin L. White
Director and Executive Chair